Skip to main content

SSRIs increase the risk of falls in patients with Dementia


January 19, 2012 - Nursing home residents with dementia who are selected using serotonin inhibitors reuptake (SSRIs), a decline that SSRIs, new research shows do not use the injury as compared withrisk is increased.In addition, the risk is dose dependent, average nonusers, authors, Rotterdam, Erasmus University Medical Centre, Netherlands, reported in S. Carolyn Sterke, MSc, lead 3 times the risk compared with those using food with.

 
Carolyn Sterke
"Even at low doses, SSRIs in nursing home residents with dementia fall hazards are associated with a growing danger," the authors write.A hypnotic or sedative SSRI use with increased risk include even more.The study, published online January 18 in the British Journal of Clinical Pharmacology are.Vulnerable population"The poor are elderly patients," Josepha A. I Cheong, MD, University of Florida College of Medicine, Gainesville, Florida, who was not involved in the research professor of psychiatry, Medscape Medical News has reported.reaction or is likely to potentiate the side effects, including increased sedation, which may predispose a patient is definitely lacking, "he said.The study investigators analyzed the daily drug use and comes on every 2-year period, 248 nursing home residents with dementia January 1, 2006 January 1, 2008. The average age of participants was 82 years.Falls investigators SSRIs and antipsychotics, anxiolytics, hypnotics, sedatives, antidiabetic drugs, beta-blocker eyedrops, cardiovascular drugs, analgesics, anticholinergics, antihistamines, and antivertigo drug is known to increase risk, including other drugs and foods produced using , copies of medical records from the database.The most common SSRI citalopram, followed by paroxetine,,,, sertraline, and fluvoxamine was from. tricyclic antidepressants amitriptyline and nortriptyline were also used, including other antidepressants trazodone and mirtazapine.Need for new treatment protocolsDuring the study period, 152 residents (61.5%) had 683 falls. Thirty eight residents (15.4%) fell once, 114 (46.2%) fell often, authors are reported.Of falls (220 or 32.2%) resulted in a third of an injury. These falls, 10 (1.5%) resulted in a hip fracture, 11 injured in the (1.6%) were other fractures. One resident died as a result of a fall.Furthermore, the 198 falls (30.0%) injuries in other types of open wounds, sprains, bruises, swellings and other results.The study showed that the resulting reduction in the risk of injury increased with age (hazard ratio [HR], 1.05, 95% confidence interval [CI] 1.01 - 1.09), and use of antipsychotics (HR 1.76, 1.18 inCI 95% - 2,63).Increased risk of falls only SSRIs, was seen with the authors of the report. Overall, SSRIs associated with the use of HR 2.50 (- 4.19 95% CI, 1.50) did.The risk of dose dependence is seen with high doses of SSRI was with. Less than a quarter of defined daily doses, the risk increased 31 percent, half the risk in defined daily dose is increased by 73 percent and total daily dose, 198% increase risk (2.98 HR; 95 % CI, 1,94 - 4.57).The authors list several limitations of the study. The different characteristics of the patient, possible talks cytochrome P450, and other drug use, such as benzodiazepines, antihypertensives, and antipsychotics are, concomitantly SSRs with include.Caution when prescribingDevelopment should consider, "he said in a statement that Ms. Sterke."The reason that people fall more often when using these drugs, including SSRIs. Think," he told Medscape Medical News."Central nervous system adverse effects have been other studies, such as daytime drowsiness, sedation, dizziness, extrapyramidal symptoms and Orthostatic hypotension and syncope, which affects the motor system is increased risk of falls with SSRI use To link has been proposed as possible explanations., "he said.Ms. Sterke also believe that doctors prescribe SSRIs to patients before they should be very careful.should be., he said. ""The study results of depression in nursing home professionals to help residents and residents with positive investment activities initiated and helped to demonstrate the least bit worried," he said."The authors take into account other drugs, but how do you say that the falls were due to SSRIs and other drugs can not," Dr. Cheong is the point."We already know that SSRIs and other medications to prevent drug metabolism in small quantities, or may be less than SSRIs authors also say that several factors may be responsible. Study if they had a strong age . nondemented people who were on the same drug combination, "he said.Dr Cheong also said that depression and dementia in nursing home patients, SSRIs may be wrong to prevent a major factor."The most clinicians approach patients on multiple medication regimen when adding an SSRI to monitor the alarm is due, he said.''

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...